<div id="readability-page-1"><div>ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before March 9, 2026. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Ardent did not rely on “detailed reviews of historical collections” to determine what accounts receivable were still collectable, despite its claims to investors. The Company “utilized a 180-day cliff at which time an account became fully reserved,” an approach that allowed it to delay recognizing losses on uncollectable accounts. The Company failed to maintain appropriate levels of professional malpractice liability insurance. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Ardent, investors suffered damages. Join the case to recover your losses The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. <img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjAxMTAzODExMzNyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjAxMTAzODExMzNyMQ"/> The Schall Law Firm Brian Schall, Esq., www.schallfirm.com Office: 310-301-3335 info@schallfirm.com View source version on businesswire.com: https://www.businesswire.com/news/home/20260110381133/en/</div></div>

ARDT

Schall 律師事務所提醒投資者，針對 Ardent Health, Inc.（紐約證券交易所代碼：ARDT）提起的證券欺詐集體訴訟。購買了 2024 年 7 月 18 日至 2025 年 11 月 12 日期間股票的投資者，鼓勵在 2026 年 3 月 9 日前聯繫該事務所。訴訟指控 Ardent 對其應收賬款和保險水平做出了虛假陳述，導致當真相浮出水面時投資者遭受損失。該集體尚未獲得認證，感興趣的股東可以加入此案以追回損失

ARDT 投資者有機會與 Schall 律師事務所合作，主導針對 Ardent Health, Inc.的證券欺詐訴訟